A Chronicle of Hybrid Atrial Fibrillation Ablation Therapy: From Cox Maze to Convergent

The burden of AF is increasing in prevalence and healthcare resource usage in the UK and worldwide. It can result in impaired quality of life for affected patients, as well as increased risk of stroke, heart failure and mortality. A holistic, integrated approach to AF management is recommended, whic...

Full description

Saved in:
Bibliographic Details
Main Authors: Riyaz A Kaba, Omar Ahmed, Elijah Behr, Aziz Momin
Format: Article
Language:English
Published: Radcliffe Medical Media 2022-07-01
Series:Arrhythmia & Electrophysiology Review
Online Access:https://www.aerjournal.com/articleindex/aer.2022.05
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850104558931410944
author Riyaz A Kaba
Omar Ahmed
Elijah Behr
Aziz Momin
author_facet Riyaz A Kaba
Omar Ahmed
Elijah Behr
Aziz Momin
author_sort Riyaz A Kaba
collection DOAJ
description The burden of AF is increasing in prevalence and healthcare resource usage in the UK and worldwide. It can result in impaired quality of life for affected patients, as well as increased risk of stroke, heart failure and mortality. A holistic, integrated approach to AF management is recommended, which may include a focus on reducing risk factors and on medical management with anticoagulation and anti-arrhythmic drugs. There are also various ablation strategies that may be considered when anti-arrhythmic drugs fail to alleviate symptoms and reduce AF burden. These ablation techniques range from standalone percutaneous endocardial catheter ablation to open surgical ablation procedures concomitant with cardiac surgery. More recently, hybrid ablation that combines aspects of both surgical and electrophysiologically targeted ablation has been described. This article reviews the evolution of ablation strategies, beginning with the origin of the Cox maze IV procedure and continuing to the recent hybrid convergent approach, and provides a summary of the associated outcomes.
format Article
id doaj-art-702c32a2c26e41a7afc94c12fe41b017
institution DOAJ
issn 2050-3369
2050-3377
language English
publishDate 2022-07-01
publisher Radcliffe Medical Media
record_format Article
series Arrhythmia & Electrophysiology Review
spelling doaj-art-702c32a2c26e41a7afc94c12fe41b0172025-08-20T02:39:18ZengRadcliffe Medical MediaArrhythmia & Electrophysiology Review2050-33692050-33772022-07-011110.15420/aer.2022.05A Chronicle of Hybrid Atrial Fibrillation Ablation Therapy: From Cox Maze to ConvergentRiyaz A Kaba0Omar Ahmed1Elijah Behr2Aziz Momin3Cardiovascular Clinical Academic Group, Molecular and Clinical Sciences Institute, St George’s, University of London and St George’s University Hospitals NHS Foundation Trust, London, UK; Department of Cardiology, Ashford and St Peter’s NHS Foundation Trust, Chertsey, Surrey, UKCardiovascular Clinical Academic Group, Molecular and Clinical Sciences Institute, St George’s, University of London and St George’s University Hospitals NHS Foundation Trust, London, UKCardiovascular Clinical Academic Group, Molecular and Clinical Sciences Institute, St George’s, University of London and St George’s University Hospitals NHS Foundation Trust, London, UKCardiovascular Clinical Academic Group, Molecular and Clinical Sciences Institute, St George’s, University of London and St George’s University Hospitals NHS Foundation Trust, London, UK; Department of Cardiology, Ashford and St Peter’s NHS Foundation Trust, Chertsey, Surrey, UKThe burden of AF is increasing in prevalence and healthcare resource usage in the UK and worldwide. It can result in impaired quality of life for affected patients, as well as increased risk of stroke, heart failure and mortality. A holistic, integrated approach to AF management is recommended, which may include a focus on reducing risk factors and on medical management with anticoagulation and anti-arrhythmic drugs. There are also various ablation strategies that may be considered when anti-arrhythmic drugs fail to alleviate symptoms and reduce AF burden. These ablation techniques range from standalone percutaneous endocardial catheter ablation to open surgical ablation procedures concomitant with cardiac surgery. More recently, hybrid ablation that combines aspects of both surgical and electrophysiologically targeted ablation has been described. This article reviews the evolution of ablation strategies, beginning with the origin of the Cox maze IV procedure and continuing to the recent hybrid convergent approach, and provides a summary of the associated outcomes.https://www.aerjournal.com/articleindex/aer.2022.05
spellingShingle Riyaz A Kaba
Omar Ahmed
Elijah Behr
Aziz Momin
A Chronicle of Hybrid Atrial Fibrillation Ablation Therapy: From Cox Maze to Convergent
Arrhythmia & Electrophysiology Review
title A Chronicle of Hybrid Atrial Fibrillation Ablation Therapy: From Cox Maze to Convergent
title_full A Chronicle of Hybrid Atrial Fibrillation Ablation Therapy: From Cox Maze to Convergent
title_fullStr A Chronicle of Hybrid Atrial Fibrillation Ablation Therapy: From Cox Maze to Convergent
title_full_unstemmed A Chronicle of Hybrid Atrial Fibrillation Ablation Therapy: From Cox Maze to Convergent
title_short A Chronicle of Hybrid Atrial Fibrillation Ablation Therapy: From Cox Maze to Convergent
title_sort chronicle of hybrid atrial fibrillation ablation therapy from cox maze to convergent
url https://www.aerjournal.com/articleindex/aer.2022.05
work_keys_str_mv AT riyazakaba achronicleofhybridatrialfibrillationablationtherapyfromcoxmazetoconvergent
AT omarahmed achronicleofhybridatrialfibrillationablationtherapyfromcoxmazetoconvergent
AT elijahbehr achronicleofhybridatrialfibrillationablationtherapyfromcoxmazetoconvergent
AT azizmomin achronicleofhybridatrialfibrillationablationtherapyfromcoxmazetoconvergent
AT riyazakaba chronicleofhybridatrialfibrillationablationtherapyfromcoxmazetoconvergent
AT omarahmed chronicleofhybridatrialfibrillationablationtherapyfromcoxmazetoconvergent
AT elijahbehr chronicleofhybridatrialfibrillationablationtherapyfromcoxmazetoconvergent
AT azizmomin chronicleofhybridatrialfibrillationablationtherapyfromcoxmazetoconvergent